NCT00320606View on ClinicalTrials.gov

Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 5, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

March 13, 2017

Conditions
Liver TransplantLiver Transplantation
Interventions
DRUG

Immunosuppression Withdrawal

Gradual withdrawal of immunosuppressive medication. With high dose, daily dose reduction by 25% for 8 weeks. With low dose, daily dose reduction by 25% for 4 weeks.

Trial Locations (3)

10032

Columbia University Medical Center, New York

60614

Children's Memorial Hospital, Chicago

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

Immune Tolerance Network (ITN)

NETWORK

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00320606 - Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients | Biotech Hunter | Biotech Hunter